Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1578, 2007-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Novel integrase inhibitor promising in triple-class resistant HIV-1
Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. :
Access to resources
Recommend
Raltegravir sets new BENCHMRK in treatment-resistant HIV
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
Raltegravir: an integrase inhibitor for HIV-1
By Evering Teresa H Markowitz Martin
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :
Raltegravir gives new hope to HIV patients
Inpharma, Vol. 1, Iss. 1599, 2007-01 ,pp. :
STARTMRK sets pace for raltegravir's first-line finish for HIV
Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. :